In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Phil Parkinson must turn his attention back to cup action on Tuesday night though as Wrexham take on Port Vale in the EFL ...

Funds raised aid in the battle against Parkinson's Disease and the related ALS (Amyotrophic Lateral Sclerosis) and PSP (Progressive Supranuclear Palsy). Need a break? Play the USA TODAY Daily ...

Readers 60 to 85 share stories of how cycling, and running, are their own fountains of youth. The doctor is not always right.

Wrexham are back in action on Tuesday night as Phil Parkinson prepares his side for EFL Trophy action against League Two side ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

From this you can see that Virtually Parkinson was never intended to replace a host but to be an experiment in interaction ...

Midway through first term as L.A. County sheriff, Robert Luna told The Times that speculation he might step down is "not true ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...